To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Protecting Equal Access to Thyroid Act of 2026. H.R. 8630. 119th
Cong., 2nd
sess., Introduced in House April 30, 2026. https://www.govinfo.gov/app/details/BILLS-119hr8630ih.
APA
Congress, House of Representatives (2026, April 30). Protecting Equal Access to Thyroid Act of 2026 (H.R. 8630 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr8630ih.
MLA
United States, Congress, House of Representatives. Protecting Equal Access to Thyroid Act of 2026. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr8630ih. 119th Congress, H.R. 8630, Introduced in House 30 Apr. 2026.
Bluebook
H.R.8630 - 119th Congress (2025-2026): Protecting Equal Access to Thyroid Act of 2026, H.R.8630, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119hr8630ih.
